1-3 of 3
William E. Carson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck Cancer

Erin M. Bertino, Elizabeth L. McMichael, Xiaokui Mo, Prashant Trikha, Melanie Davis, Bonnie Paul, Michael Grever, William E. Carson, Gregory A. Otterson
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (9): 2244–2250.
https://doi.org/10.1158/1535-7163.MCT-15-0879
Published: 01 September 2016
View article titled, A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck Cancer
Open the PDF for A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Interleukin-29 Binds to Melanoma Cells Inducing Jak-STAT Signal Transduction and Apoptosis

Kristan D. Guenterberg, Valerie P. Grignol, Ene T. Raig, Jason M. Zimmerer, Anthony N. Chan, Farriss M. Blaskovits, Gregory S. Young, Gerard J. Nuovo, Bethany L. Mundy, Gregory B. Lesinski, William E. Carson, III
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (2): 510–520.
https://doi.org/10.1158/1535-7163.MCT-09-0461
Published: 09 February 2010
View article titled, Interleukin-29 Binds to Melanoma Cells Inducing Jak-STAT Signal Transduction and Apoptosis
Open the PDF for Interleukin-29 Binds to Melanoma Cells Inducing Jak-STAT Signal Transduction and Apoptosis in another window
Journal Articles

A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies

Tanios S. Bekaii-Saab, Julie M. Roda, Kristan D. Guenterberg, Bhuvanaswari Ramaswamy, Donn C. Young, Amy K. Ferketich, Tammy A. Lamb, Michael R. Grever, Charles L. Shapiro, William E. Carson, III
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (11): 2983–2991.
https://doi.org/10.1158/1535-7163.MCT-09-0820
Published: 10 November 2009
View article titled, A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies
Open the PDF for A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies in another window